摘要
目的:基于自主研发的合理用药系统实施中成药处方点评并评价其效果,以促进中成药的临床合理应用。方法:利用自主研发的合理用药系统对我院2019年1-6月(实施前)和2020年1-6月(实施后)的中成药处方进行全处方和分类专项处方点评,并结合药师的人工点评,比较两个时间段的不合理用药情况,评价基于合理用药系统进行处方点评的效果。结果:我院中成药全处方点评结果显示,实施后中成药处方不合格率为1.5%,较实施前的5.6%显著降低(P<0.05)。中成药专项处方点评结果显示,实施前中药注射剂、含毒性药材中成药和急救中成药的处方不合格率分别为11.8%、10.7%和11.0%,而实施后分别为3.6%、4.2%和6.6%,较实施前均显著降低(P<0.05)。结论:采用自主研发的合理用药系统进行中成药全处方点评与专项点评的效果显著,提高了我院中成药合理用药水平。
OBJECTIVE:To conduct the prescription comment of Chinese patent medicine based on self-developed rational drug use system and evaluate its effect,and to promote rational use of Chinese patent medicine.METHODS:The self-developed rational drug use system was used to evaluate the complete prescriptions and classified special prescriptions of Chinese patent medicines in our hospital from Jan.to Jun.2019(before implementation)and from Jan.to Jun.2020(after implementation);combined with pharmacists’manual comments,the situation of irrational drug use in the two periods was compared,and the effect of prescription comment by rational drug use system was evaluated.RESULTS:Results of full prescription comment of Chinese patent medicine in our hospital showed that the unqualified rate of Chinese patent medicine prescriptions was 1.5%,which was significantly lower than 5.6%before the implementation(P<0.05).Results of special prescription comment of Chinese patent medicine showed that the unqualified rates of TCM injection,toxic Chinese patent medicines and emergency Chinese patent medicines were 11.8%,10.7%,11.0%before implementation;while after implementation,they were 3.6%,4.2%and 6.6%,which were significantly lower than before implementation(P<0.05).CONCLUSIONS:Self-developed rational drug use system of Chinese patent medicine shows remarkable effect on full prescription comment and special comment,which greatly improves the level of rational drug use of Chinese patent medicines in our hospital.
作者
秦娜
吴晓龙
张虹
QIN Na;WU Xiaolong;ZHANG Hong(Dept.of Pharmacy,Luoyang Orthopedic Traumatology Hospital(Orthopedics Hospital of Henan Province),Henan Luoyang 471000,China)
出处
《中国药房》
CAS
北大核心
2021年第11期1382-1385,共4页
China Pharmacy
基金
河南省科技发展计划项目(No.162102310367)
河南省中医药科学研究专项课题(No.2015ZY02064)
洛阳市科技计划医疗卫生项目(No.1603004A-9)。
关键词
中成药
合理用药系统
处方点评
Chinese patent medicine
Rational drug use system
Prescription comment
作者简介
秦娜,副主任药师,博士。研究方向:临床药学。E-mail:qinna2001@163.com;通信作者:张虹,主任药师,硕士生导师,硕士。研究方向:临床药学。E-mail:lyzgzh2008@163.com。
